12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·04/15/2026 12:05:43
Listen to the news
Gainers
Immutep (NASDAQ:IMMP) shares rose 135.4% to $0.74 during Wednesday's pre-market session. The market value of their outstanding shares is at $46.3 million.
ENDRA Life Sciences (NASDAQ:NDRA) stock moved upwards by 13.1% to $5.61. The market value of their outstanding shares is at $6.1 million.
Medicus Pharma (NASDAQ:MDCX) stock moved upwards by 12.15% to $0.45. The company's market cap stands at $11.9 million.
Liminatus Pharma (NASDAQ:LIMN) stock rose 9.53% to $0.2. The market value of their outstanding shares is at $7.0 million.
BrainsWay (NASDAQ:BWAY) stock moved upwards by 8.41% to $16.23. The company's market cap stands at $599.2 million.
Acurx Pharmaceuticals (NASDAQ:ACXP) stock increased by 7.55% to $2.99. The market value of their outstanding shares is at $7.9 million.
Losers
Aspire Biopharma Holdings (NASDAQ:ASBP) stock fell 28.2% to $0.85 during Wednesday's pre-market session. The company's market cap stands at $5.9 million.
HeartBeam (NASDAQ:BEAT) stock fell 25.36% to $0.9. The company's market cap stands at $49.3 million.
Curanex Pharmaceuticals (NASDAQ:CURX) stock fell 24.99% to $0.35. The company's market cap stands at $13.1 million.
Wellgistics Health (NASDAQ:WGRX) shares fell 20.2% to $0.12. The company's market cap stands at $18.3 million.
Clearmind Medicine (NASDAQ:CMND) shares declined by 16.58% to $0.76. The market value of their outstanding shares is at $2.1 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.